Deutsch English Français

Contact

EP1861423

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1861423

EP1861423 - MOLECULES AND CHIMERIC MOLECULES THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 03.09.2010 Database last updated on 03.10.2024
Most recent event Tooltip	03.09.2010	Application deemed to be withdrawn	published on 06.10.2010 [2010/40]
Applicant(s)	For all designated states Apollo Life Sciences Limited Level 1, 147 Queen Street Beaconsfield, New South Wales 2015 / AU
	[2007/49]
Inventor(s)	01 / PRIEST, John D 12b Grafton Street Balmain, New South Wales 2041 / AU
	02 / WATTS, Alan D 31 Undercliffe Street Dee Why, New South Wales 2099 / AU
	03 / WHITTAKER, Jason S 24 Maddison Street Redfern East, New South Wales 2016 / AU
	04 / PILKINGTON, Glenn R 6 Allara Street Rye, Victoria 3941 / AU
	05 / LIDDELL, Catherine A 6 Caroline Street Kingsgrove, New South Wales 2208 / AU
	[2007/49]
Representative(s)	Dzieglewska, Hanna Eva Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD / GB
	[N/P]
Former [2007/49]	Dzieglewska, Hanna Eva Frank B. Dehn & Co. St Bride's House 10 Salisbury Square London EC4Y 8JD / GB
Application number, filing date	05804566.7	24.11.2005
	[2007/49]
	WO2005AU01780
Priority number, date	US20050653323P	15.02.2005 Original published format: US 653323 P
	[2007/49]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2006086823
	Date:	24.08.2006
	Language:	EN
	[2006/34]
	Type:	A1 Application with search report
	No.:	EP1861423
	Date:	05.12.2007
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.08.2006 takes the place of the publication of the European patent application.
	[2007/49]
Search report(s)	International search report - published on:	AU	24.08.2006
	(Supplementary) European search report - dispatched on:	EP	29.12.2009
Classification	IPC:	C07K14/55, C07K16/06, C07K14/715, C07K19/00, A61K38/20, C07H21/04, C07H21/02, A61P31/20	[2007/49]
	CPC:	C07K14/55 (EP,US); A61P31/20 (EP); A61P37/04 (EP); C07K14/7155 (EP,US); A61K38/00 (EP,US); C07K2319/30 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/49]
Extension states	AL	Not yet paid
	BA	Not yet paid
	HR	Not yet paid
	MK	Not yet paid
	YU	Not yet paid
Title	German:	MOLEKÜLE UND CHIMERE MOLEKÜLE DAVON	[2007/49]
	English:	MOLECULES AND CHIMERIC MOLECULES THEREOF	[2007/49]
	French:	MOLÉCULE ET MOLÉCULES CHIMÈRES DE CELLE-CI	[2007/49]
Entry into regional phase	17.09.2007	National basic fee paid
	17.09.2007	Search fee paid
	17.09.2007	Designation fee(s) paid
	17.09.2007	Examination fee paid
Examination procedure	17.09.2007	Amendment by applicant (claims and/or description)
	17.09.2007	Examination requested [2007/49]
	26.03.2010	Application deemed to be withdrawn, date of legal effect [2010/40]
	17.05.2010	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/40]
Fees paid	Renewal fee
	17.09.2007	Renewal fee patent year 03
	27.11.2008	Renewal fee patent year 04
	Penalty fee
	Additional fee for renewal fee
	30.11.2009	05 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]US2002193305 (RUBEN STEVEN M [US], et al) [A] 1-4,8-24* paragraph [0147] - paragraph [0148]; example 10 *;
		[A]US6589764 (SIMS JOHN E [US], et al) [A] 1-4,8-24 * column 6, line 50 - column 7, line 67; example - *;
		[X] - YOSHIDA YOKO ET AL, "Generation of fiber-mutant recombinant adenoviruses for gene therapy of malignant glioma", HUMAN GENE THERAPY, (19981120), vol. 9, no. 17, ISSN 1043-0342, pages 2503 - 2515, XP002927076 [X] 1-4,9,13-24 * the whole document * DOI: http://dx.doi.org/10.1089/10430349850019346
		[X] - NAGASHIMA SHIGEKI ET AL, "In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2", CANCER GENE THERAPY, (199711), vol. 4, no. 6, ISSN 0929-1903, pages 366 - 376, XP009126472 [X] 1-4,9,13-24 * the whole document *
		[X] - ONG EDGAR ET AL, "Purification of human interleukin-2 using the cellulose-binding domain of a prokaryotic cellulase", BIOSEPARATION, (1995), vol. 5, no. 2, ISSN 0923-179X, pages 95 - 104, XP000671067 [X] 1-4,9-10,13-24 * the whole document *
		[X] - KNEZEVIC M ET AL, "Human interleukin-2 (IL-2) expressed by transfected mammalian cells", PFLUEGERS ARCHIV: EUROPEAN JOURNAL OF PHYSIOLOGY, SPRINGER VERLAG, BERLIN, DE, (19960101), vol. 431, no. suppl. 2, ISSN 0031-6768, pages R227 - R228, XP009126471 [X] 1-4,9,13-24 * the whole document * DOI: http://dx.doi.org/10.1007/BF02346351
		[X] - MARCHESE E ET AL, "Separation by cation-exchange high-performance liquid chromatography of three forms of Chinese hamster ovary cell-derived recombinant human interleukin-2.", JOURNAL OF CHROMATOGRAPHY 20 APR 1990, (19900420), vol. 504, no. 2, ISSN 0021-9673, pages 351 - 358, XP002558024 [X] 1-4,9,13-24 * the whole document * DOI: http://dx.doi.org/10.1016/S0021-9673(01)89538-8
		[X] - CONRADT H S ET AL, "SECRETION OF GLYCOSYLATED HUMAN INTERLEUKIN-2 BY RECOMBINANT MAMMALIAN CELL LINES", CARBOHYDRATE RESEARCH, & THIRD EUROPEAN SYMPOSIUM ON CARBOHYDRATES, GRENOBLE, FRANCE, SEPT. 16-20, 1985. CARBOHYDR RES., (1986), vol. 149, no. 2, ISSN 0008-6215, pages 443 - 450, XP026634489 [X] 1-4,9,13-24 * the whole document * DOI: http://dx.doi.org/10.1016/S0008-6215(00)90064-8
		[X] - VITA N ET AL, "CLOSELY RELATED GLYCOSYLATION PATTERNS OF RECOMBINANT HUMAN IL-2 EXPRESSED IN A CHO CELL LINE AND NATURAL IL-2", LYMPHOKINE RESEARCH, (1990), vol. 9, no. 1, ISSN 0277-6766, pages 67 - 80, XP009126470 [X] 1-4,9,13-24 * the whole document *
		[X] - CONRADT H S ET AL, "Expression of human interleukin-2 in recombinant baby hamster kidney ltk-, and chinese hamster ovary cells /STRUCTURE OF O-LINKED CARBOHYDRATE CHAINS AND THEIR LOCATION WITHIN THE POLYPEPTIDE", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM, US, (19891015), vol. 264, no. 29, ISSN 0021-9258, pages 17368 - 17373, XP003017499 [X] 1-4,9,13-24 * the whole document *
		[X] - TANIGUCHI T ET AL, "Structure and expression of a cloned cDNA for human interleukin-2.", NATURE 1983 MAR 24-30, (19830324), vol. 302, no. 5906, ISSN 0028-0836, pages 305 - 310, XP002558027 [X] 1-4,9,13-24 * the whole document * DOI: http://dx.doi.org/10.1038/302305a0
		[A] - KUZIEL W A ET AL, "Interleukin-2 and the IL-2 receptor: new insights into structure and function.", THE JOURNAL OF INVESTIGATIVE DERMATOLOGY JUN 1990, (199006), vol. 94, no. 6 Suppl, ISSN 0022-202X, pages 27S - 32S, XP002558028 [A] 1-4,8-24 * the whole document * DOI: http://dx.doi.org/10.1111/1523-1747.ep12875017
	International search	[X]JPS6153300 ;
		[XP]WO2005021592 (MERCK PATENT GMBH [DE], et al);
		[X]WO2005007121 (MASSACHUSETTS INST TECHNOLOGY [US], et al);
		[X]WO03031464 ;
		[X]WO02066514 (MERCK PATENT GMBH [DE], et al);
		[X]US5824330 (MERTELSMANN ROLAND [US], et al);
		[X]US4908434 (MERTELSMANN ROLAND [US], et al);
		[X]US4925919 (MERTELSMANN ROLAND [US], et al);
		[X]US4751183 (SONNEBORN HANS H [DE], et al)
		[X] - CHO M.S. ET AL., "Establishment of a human somatic hybrid cell line for recombinant protein production", J. BIOMED. SCI., (200211), vol. 9, no. 6 PT 2, pages 631 - 638, XP008118040 DOI: http://dx.doi.org/10.1007/BF02254991
		[X] - ZHENG X.X. ET AL., "Il-2 receptor-targeted cytolytic Il-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice", J. IMMUNOL., (19991001), vol. 163, no. 7, pages 4041 - 4048, XP002230805
		[X] - ZHANG W.Y. ET AL., "Rapid purification of a new humanized single-chain Fv antibody/human interleukin-2 fusion protein reactive against HER2 receptor", ACTA BIOCHIM BIOPHYS SIMICA (SHANGHAI), (200410), vol. 36, no. 10, pages 707 - 712, XP008118072 DOI: http://dx.doi.org/10.1093/abbs/36.10.707
		[X] - DATABASE WPI, 1, Derwent World Patents Index, vol. 1986, no. 17, Database accession no. 1986-110375, XP008113408 & JPS6153300 A 19860317 (TAKEDA CHEMICAL IND KK)
		[X] - DATABASE WPI, 1, Derwent World Patents Index, vol. 2003, no. 42, Database accession no. 2003-449162, XP008113409 & WO03031464 A2 20030417 (NEOSE TECHNOLOGIES INC.)
		[X] - SUTTMANN H. ET AL., "Stimulation of neutrophil granulocytes with Mycobacterium bovis bacillus Calmete-Guerin induces changes in phenotype and gene expression and inhibits spontaneous apoptosis", INFECTION AND IMMUNITY, (200308), vol. 71, no. 8, pages 4647 - 4656, XP008117975 DOI: http://dx.doi.org/10.1128/IAI.71.8.4647-4656.2003
		[X] - KREITMAN R.J., "Toxin-labeled monoclonal antibodies", CURRENT PHARMACEUTICAL BIOTECHNOLOGY, (200112), vol. 2, no. 4, pages 313 - 325, XP008118070
		[X] - TERAMOTO H. ET AL., "Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway", JOURNAL OF BIOLOGICAL CHEMISTRY, (19970418), vol. 272, no. 16, pages 10751 - 10755, XP008117974 DOI: http://dx.doi.org/10.1074/jbc.272.16.10751

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p